Temporal trends in stroke incidence and case-fatality rates in Arcadia, Greece: A sequential, prospective, population-based study.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 3 2 2021
medline: 11 1 2022
entrez: 2 2 2021
Statut: ppublish

Résumé

Stroke incidence and case-fatality are reported to decline in high-income countries during the last decades. Epidemiological studies are important for health services to organize prevention and treatment strategies. The aim of this population-based study was to determine temporal trends of stroke incidence and case-fatality rates of first-ever stroke in Arcadia, a prefecture in southern Greece. All first-ever stroke cases in the Arcadia prefecture were ascertained using the same standard criteria and multiple overlapping sources in three study periods: from November 1993 to October 1995; 2004; and 2015-2016. Crude and age-adjusted to European population incidence rates were compared using Poisson regression. Twenty-eight days case fatality rates were estimated and compared using the same method. In total, 1315 patients with first-ever stroke were identified. The age-standardized incidence to the European population was 252 per 100,000 person-years (95% CI 231-239) in 1993/1995, 252 (95% CI 223-286) in 2004, and 211 (192-232) in 2015/2016. The overall age- and sex-adjusted incidence rates fell by 16% (incidence rates ratio 0.84, 95% CI: 0.72-0.97). Similarly, 28-day case-fatality rate decreased by 28% (case fatality rate ratio = 0.72, 95% CI: 0.58-0.90). This population-based study reports a significant decline in stroke incidence and mortality rates in southern Greece between 1993 and 2016.

Sections du résumé

BACKGROUND
Stroke incidence and case-fatality are reported to decline in high-income countries during the last decades. Epidemiological studies are important for health services to organize prevention and treatment strategies.
AIMS
The aim of this population-based study was to determine temporal trends of stroke incidence and case-fatality rates of first-ever stroke in Arcadia, a prefecture in southern Greece.
METHODS
All first-ever stroke cases in the Arcadia prefecture were ascertained using the same standard criteria and multiple overlapping sources in three study periods: from November 1993 to October 1995; 2004; and 2015-2016. Crude and age-adjusted to European population incidence rates were compared using Poisson regression. Twenty-eight days case fatality rates were estimated and compared using the same method.
RESULTS
In total, 1315 patients with first-ever stroke were identified. The age-standardized incidence to the European population was 252 per 100,000 person-years (95% CI 231-239) in 1993/1995, 252 (95% CI 223-286) in 2004, and 211 (192-232) in 2015/2016. The overall age- and sex-adjusted incidence rates fell by 16% (incidence rates ratio 0.84, 95% CI: 0.72-0.97). Similarly, 28-day case-fatality rate decreased by 28% (case fatality rate ratio = 0.72, 95% CI: 0.58-0.90).
CONCLUSIONS
This population-based study reports a significant decline in stroke incidence and mortality rates in southern Greece between 1993 and 2016.

Identifiants

pubmed: 33527879
doi: 10.1177/1747493021995594
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-47

Auteurs

Eleni Karantali (E)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.
Third Neurological Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Department of Internal Medicine, University of Thessaly, Larissa, Greece.

Konstantinos Vemmos (K)

Hellenic Stroke Organization, Athens, Greece.

Evangelos Tsampalas (E)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Konstantinos Xynos (K)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Persefoni Karachalia (P)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Dimitrios Lambrou (D)

Hellenic Stroke Organization, Athens, Greece.

Stella Angeloglou (S)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Maria Kazakou (M)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Aikaterini Karagianni (A)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Konstantina Aravantinou-Fatorou (K)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Eleftheria Karakatsani (E)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Michiel L Bots (ML)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Georgia Karamatzianni (G)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Stavros Bellos (S)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Romanos Ntiloudis (R)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Maria Lypiridou (M)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Anastasia Gamvoula (A)

Neurological Department, Arcadia General Hospital, Tripoli, Greece.

Georgios Georgiopoulos (G)

School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Erold Ajdini (E)

Department of Statistics, Athens University of Economics and Business, Athens, Greece.

Nikolaos Gatselis (N)

Department of Internal Medicine, University of Thessaly, Larissa, Greece.

Konstantinos Makaritsis (K)

Department of Internal Medicine, University of Thessaly, Larissa, Greece.

Eleni Korompoki (E)

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

George Ntaios (G)

Department of Internal Medicine, University of Thessaly, Larissa, Greece.
Hellenic Stroke Organization, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH